Status:
COMPLETED
The Adjustment of Doses in Diabetes Mellitus Type I
Lead Sponsor:
Liwa College
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
FEMALE
41-41 years
Brief Summary
The study was carried out in a diabetic patient who was starting a new approach for treatment. Previously the patient was treated with Novo-mix insulin injection twice per day, the physician decided t...
Detailed Description
In this study a diabetic patient is starting a new approach to treatment. Previously, the patient received Novo-Mix insulin injection twice per day (48 Units in breakfast \& 28 Units in dinner). Moreo...
Eligibility Criteria
Inclusion
- Diabetic patient
Exclusion
- Normal patient
Key Trial Info
Start Date :
October 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT06055829
Start Date
October 24 2022
End Date
January 20 2023
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hisham Ibrahim
Abu Dhabi, United Arab Emirates